Notch Signalling Pathways and Their Importance in the Treatment of Cancers
Journal:
Current Drug Targets
Volume:
19
Page:
128-143
Author(s):
Seong Lin Teoh and Srijit Das*
Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
177-187
Author(s):
Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell and Evanthia Galanis*
Oncolytic Viruses: The Best is Yet to Come
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
109-123
Author(s):
Chantal G. Lemay, Brian A. Keller, Robert E. Edge, Masato Abei and John C. Bell*
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
124-138
Author(s):
Vincenzo Cerullo*, Cristian Capasso, Markus Vaha-Koskela, Otto Hemminki and Akseli Hemminki*
Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
4842-4861
Author(s):
Svetlana Vinokurova*
Is there a Role for Epigenetic Enhancement of Immunomodulatory Approaches to Cancer Treatment?
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
5-15
Author(s):
Kirsty J. Flower, Sadaf Ghaem-Maghami and Robert Brown*
Multimodal HDAC Inhibitors with Improved Anticancer Activity
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
39-56
Author(s):
Rainer Schobert and Bernhard Biersack*
Epigenetic Modulation Using Small Molecules - Targeting Histone Acetyltransferases in Disease
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
4121-4150
Author(s):
Andre Richters and Angela N. Koehler*
Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
12
Page:
296-322
Author(s):
Qing-Yuan Lan, Yan-Le Zhi, Hao Heng, Jie-Yi Tian, Xiao-Xing Guo, Hai-Chun Liu, Ya-Dong Chen, Tao Lu* and Shuai Lu*
Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target
Journal:
Current Cancer Therapy Reviews
Volume:
13
Page:
76-88
Author(s):
Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang*